These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. LRRK2-Related Parkinson's Disease Due to Altered Endolysosomal Biology With Variable Lewy Body Pathology: A Hypothesis. Rivero-Ríos P; Romo-Lozano M; Fasiczka R; Naaldijk Y; Hilfiker S Front Neurosci; 2020; 14():556. PubMed ID: 32581693 [TBL] [Abstract][Full Text] [Related]
12. Rab GTPases as Physiological Substrates of LRRK2 Kinase. Seol W; Nam D; Son I Exp Neurobiol; 2019 Apr; 28(2):134-145. PubMed ID: 31138985 [TBL] [Abstract][Full Text] [Related]
13. Autosomal dominant Parkinson's disease caused by the recently identified LRRK2 N1437D mutation in a Chinese family: Clinical features, imaging findings, and functional impact. Sun YM; Gan LH; Peng F; Zhou XY; Chen QS; Liu FT; Tang YL; Wu P; Lu JY; Ge JJ; Yen TC; Zuo CT; Song B; Wu JJ; Wang J Parkinsonism Relat Disord; 2023 Jun; 111():105441. PubMed ID: 37201327 [TBL] [Abstract][Full Text] [Related]
14. The emerging role of Rab GTPases in the pathogenesis of Parkinson's disease. Gao Y; Wilson GR; Stephenson SEM; Bozaoglu K; Farrer MJ; Lockhart PJ Mov Disord; 2018 Feb; 33(2):196-207. PubMed ID: 29315801 [TBL] [Abstract][Full Text] [Related]
15. Genetic analysis of Mendelian mutations in a large UK population-based Parkinson's disease study. Tan MMX; Malek N; Lawton MA; Hubbard L; Pittman AM; Joseph T; Hehir J; Swallow DMA; Grosset KA; Marrinan SL; Bajaj N; Barker RA; Burn DJ; Bresner C; Foltynie T; Hardy J; Wood N; Ben-Shlomo Y; Grosset DG; Williams NM; Morris HR Brain; 2019 Sep; 142(9):2828-2844. PubMed ID: 31324919 [TBL] [Abstract][Full Text] [Related]
16. Serotonin and dopamine transporter PET changes in the premotor phase of LRRK2 parkinsonism: cross-sectional studies. Wile DJ; Agarwal PA; Schulzer M; Mak E; Dinelle K; Shahinfard E; Vafai N; Hasegawa K; Zhang J; McKenzie J; Neilson N; Strongosky A; Uitti RJ; Guttman M; Zabetian CP; Ding YS; Adam M; Aasly J; Wszolek ZK; Farrer M; Sossi V; Stoessl AJ Lancet Neurol; 2017 May; 16(5):351-359. PubMed ID: 28336296 [TBL] [Abstract][Full Text] [Related]
17. Dysregulated phosphorylation of Rab GTPases by LRRK2 induces neurodegeneration. Jeong GR; Jang EH; Bae JR; Jun S; Kang HC; Park CH; Shin JH; Yamamoto Y; Tanaka-Yamamoto K; Dawson VL; Dawson TM; Hur EM; Lee BD Mol Neurodegener; 2018 Feb; 13(1):8. PubMed ID: 29439717 [TBL] [Abstract][Full Text] [Related]
18. The Lange LM; Levine K; Fox SH; Marras C; Ahmed N; Kuznetsov N; Vitale D; Iwaki H; Lohmann K; Marsili L; Espay AJ; Bauer P; Beetz C; Martin J; Factor SA; Higginbotham LA; Chen H; Leonard H; Nalls M; Mencacci NE; Morris HR; Klein C; Blauwendraat C; Fang ZH; Res Sq; 2024 Sep; ():. PubMed ID: 39372927 [TBL] [Abstract][Full Text] [Related]
19. Endogenous Rab38 regulates LRRK2's membrane recruitment and substrate Rab phosphorylation in melanocytes. Unapanta A; Shavarebi F; Porath J; Shen Y; Balen C; Nguyen A; Tseng J; Leong WS; Liu M; Lis P; Di Pietro SM; Hiniker A J Biol Chem; 2023 Oct; 299(10):105192. PubMed ID: 37625589 [TBL] [Abstract][Full Text] [Related]